Creative Medical Technology Holdings Inc
CELZ2.220USD
+0.050+2.30%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
5.73MMarket Cap
LossP/E TTM
More Details of Creative Medical Technology Holdings Inc Company
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
Creative Medical Technology Holdings Inc Info
Ticker SymbolCELZ
Company nameCreative Medical Technology Holdings Inc
IPO dateMay 01, 2009
CEOWarbington (Timothy)
Number of employees4
Security typeOrdinary Share
Fiscal year-endMay 01
Address211 E. Osborn Rd.
CityPHOENIX
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code85012
Phone14803992822
Websitehttps://creativemedicaltechnology.com/
Ticker SymbolCELZ
IPO dateMay 01, 2009
CEOWarbington (Timothy)
Company Executives of Creative Medical Technology Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Timothy Warbington
Mr. Timothy Warbington
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
12.21K
--
Mr. Donald Dickerson
Mr. Donald Dickerson
Chief Financial Officer, Senior Vice President, Director
Chief Financial Officer, Senior Vice President, Director
17.00
--
Mr. Michael H. Finger
Mr. Michael H. Finger
Independent Director
Independent Director
--
--
Mr. Bruce S. Urdang, Esq.
Mr. Bruce S. Urdang, Esq.
Independent Director
Independent Director
--
--
Ms. Susan Hegarty Snow
Ms. Susan Hegarty Snow
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Timothy Warbington
Mr. Timothy Warbington
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
12.21K
--
Mr. Donald Dickerson
Mr. Donald Dickerson
Chief Financial Officer, Senior Vice President, Director
Chief Financial Officer, Senior Vice President, Director
17.00
--
Mr. Michael H. Finger
Mr. Michael H. Finger
Independent Director
Independent Director
--
--
Mr. Bruce S. Urdang, Esq.
Mr. Bruce S. Urdang, Esq.
Independent Director
Independent Director
--
--
Ms. Susan Hegarty Snow
Ms. Susan Hegarty Snow
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, Dec 14
Updated: Sun, Dec 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
0.74%
Geode Capital Management, L.L.C.
0.67%
Creative Medical Health, Inc.
0.65%
DRW Securities, LLC
0.43%
Warbington (Timothy)
0.35%
Other
97.16%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
0.74%
Geode Capital Management, L.L.C.
0.67%
Creative Medical Health, Inc.
0.65%
DRW Securities, LLC
0.43%
Warbington (Timothy)
0.35%
Other
97.16%
Shareholder Types
Shareholders
Proportion
Investment Advisor
1.37%
Investment Advisor/Hedge Fund
0.67%
Corporation
0.65%
Individual Investor
0.48%
Research Firm
0.03%
Other
96.80%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
27
72.58K
11.84%
--
2025Q3
29
72.58K
11.88%
+776.00
2025Q2
25
71.80K
10.72%
-129.79K
2025Q1
23
201.59K
4.41%
+89.66K
2024Q4
25
29.86K
7.67%
-49.38K
2024Q3
28
77.15K
11.92%
-653.00
2024Q2
30
77.93K
20.77%
-35.91K
2024Q1
32
113.90K
14.79%
-86.68K
2023Q4
34
27.41K
16.84%
+6.21K
2023Q3
38
90.73K
17.10%
+463.00
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
17.63K
0.68%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
20.88K
0.81%
+2.61K
+14.28%
Jun 30, 2025
Creative Medical Health, Inc.
22.70K
0.88%
--
--
Apr 15, 2025
Warbington (Timothy)
12.21K
0.47%
--
--
Apr 15, 2025
Allworth Financial, L.P.
4.00K
0.15%
+4.00K
--
Jun 30, 2025
Osaic Holdings, Inc.
1.13K
0.04%
-131.00
-10.39%
Jun 30, 2025
Finger (Michael H.)
351.00
0.01%
-1.50K
-81.04%
Apr 15, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Date
Type
Ratio
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
FAQs
Who are the top five shareholders of Creative Medical Technology Holdings Inc?
The top five shareholders of Creative Medical Technology Holdings Inc are:
The Vanguard Group, Inc. holds 17.63K shares, accounting for 0.68% of the total shares.
Geode Capital Management, L.L.C. holds 20.88K shares, accounting for 0.81% of the total shares.
Creative Medical Health, Inc. holds 22.70K shares, accounting for 0.88% of the total shares.
Warbington (Timothy) holds 12.21K shares, accounting for 0.47% of the total shares.
Allworth Financial, L.P. holds 4.00K shares, accounting for 0.15% of the total shares.
The Vanguard Group, Inc. holds 17.63K shares, accounting for 0.68% of the total shares.
Geode Capital Management, L.L.C. holds 20.88K shares, accounting for 0.81% of the total shares.
Creative Medical Health, Inc. holds 22.70K shares, accounting for 0.88% of the total shares.
Warbington (Timothy) holds 12.21K shares, accounting for 0.47% of the total shares.
Allworth Financial, L.P. holds 4.00K shares, accounting for 0.15% of the total shares.
What are the top three shareholder types of Creative Medical Technology Holdings Inc?
The top three shareholder types of Creative Medical Technology Holdings Inc are:
The Vanguard Group, Inc.
Geode Capital Management, L.L.C.
Creative Medical Health, Inc.
The Vanguard Group, Inc.
Geode Capital Management, L.L.C.
Creative Medical Health, Inc.
How many institutions hold shares of Creative Medical Technology Holdings Inc (CELZ)?
As of 2025Q4, 27 institutions hold shares of Creative Medical Technology Holdings Inc, with a combined market value of approximately 72.58K, accounting for 11.84% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.04%.
What is the biggest source of revenue for Creative Medical Technology Holdings Inc?
In --, the -- business generated the highest revenue for Creative Medical Technology Holdings Inc, amounting to -- and accounting for --% of total revenue.
